Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 330

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 330
---
 | To the knowledge of the Company, there is no deficiency in the Company’s or its Subsidiary cybersecurity                                                                                                                                          
 measures or policies that is likely to result in a loss of data or a breach of security of the Company or its Subsidiary in any material respect. The Company and its Subsidiary have performed security risk assessments no less frequently than 
 annually for the past five years (collectively, the “Security Risk Assessment”). The Company and its Subsidiary have addressed and fully remediated all critical and high risk threats and deficiencies identified in each Security               
 Risk Assessment.                                                                                                                                                                                                                                  |

| 39. | Real Property |

| (a) | The Company and its Subsidiary have never owned, do not own and are not bound by or subject to any agreement or  
 option to own, in any case, directly or indirectly, any real property or any freehold interest in real property. |

| (b) | Schedule 39 to the Disclosure Letter sets forth a complete and accurate list of all Leased Properties, in each 
 case by reference to their municipal addresses.                                                                |

| (c) | Neither the Company nor its Subsidiary is in violation of any material covenants or not in compliance with any 
 material condition or restrictions under each Lease.                                                           |

A-84

| 40. | Title and Sufficiency of Company Assets |

| (a) | Each of the Company or the Subsidiary has good and marketable title to the Company Assets free and clear of any 
 Encumbrances (other than Permitted Encumbrances), in all material respects.                                     |

| (b) | The Company is not aware of any defects, failures or impairments in the title of the Company Assets, whether or                                                                                      
 not an action, suit, proceeding or inquiry is pending or threatened or whether or not discovered by any third party, which in aggregate, could reasonably be expected to be material to the Company. |

| 41. | Bank Accounts and Powers of Attorney |

Schedule 41 of the Disclosure Letter is a complete and accurate list showing (i) the name of each bank in which the Company or the Subsidiary has an account or safety deposit box and the names of all persons authorized to draw on the account or to have access to the safety deposit box; and (ii) the names of all persons holding powers of attorney from the Company or the Subsidiary. Copies of the powers of attorney, if any,